As the United States market grapples with heightened volatility and investor concerns over new tariffs, major indices like the S&P 500 and Nasdaq Composite have experienced significant fluctuations.

Amidst the turmoil in the United States stock market, with major indices like the S&P 500 and Nasdaq experiencing significant declines due to escalating trade tensions, investors are grappling with ...

Overview: CRA International, Inc. offers economic, financial, and management consulting services globally and has a market cap of approximately $1.19 billion. Operations: The primary revenue stream ...

NasdaqCM:ICG Debt to Equity as at Mar 2025 Overview: Anbio Biotechnology specializes in providing in vitro diagnostics (IVD) products globally, with a market cap of $331.82 million. Operations ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Cargo Therapeutics, a once-high-flying Bay Area biotech company that specializes in oncology research, is laying off almost its entire staff as it shuts down drug development efforts. Cargo’s ...

One day, the nitroplast may revolutionize farming. "It's one of the Holy Grails of biotechnology," says Jon Zehr, a now-retired microbial ecologist from UC Santa Cruz — the ability to engineer ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.